Skip to content

Post-ICU Consultation : a Time to Discuss Advance Directives (CoPRADA)

Post-ICU Consultation : a Time to Discuss Advance Directives

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05817500
Acronym
CoPRADA
Enrollment
40
Registered
2023-04-18
Start date
2021-12-09
Completion date
2022-12-09
Last updated
2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advance Care Planning, Advance Directives, Post Intensive Care Syndrome

Keywords

Intensive Care, Advance directives, Post Intensive Care syndrome, Post Intensive Care consultation

Brief summary

The aim of this study is to assess the possibility of discussing advance directives during post-intensive care consultation.

Detailed description

After a stay in intensive care units (ICU), patients can experience physical, psychological and cognitive impairments. To assess this post intensive care syndrom (PICS), post-ICU consultation have been developed. Since 5 year mortality is higher in ICU survivors, it might be interesting to address those patients' views relating to illness and end of life through a discussion on advance directives (AD), during post-ICU consultation. However, the development of these consultations being recent, it has not yet been assessed whether this consultations might be a suitable time to discuss AD and the intensivit a suitable interlocutor.

Interventions

None listed

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with 48 hours of mechanical ventilation * Patients with a 5 days stay in ICU

Exclusion criteria

* Patients with therapeutic limitation discussed during their ICU stay * Geographical remotness to come to the post-ICU consultation * Minor patients * Patient not affiliated to the social security scheme

Design outcomes

Primary

MeasureTime frameDescription
Number of patients willing to discuss AD after an ICU stay1 yearNumber of patient willing to discussion AD after ICU stay will be observed

Secondary

MeasureTime frameDescription
Number of patients knowing about AD before their ICU stay1 yearNumber of patient knowing before AD before ICU stay will be observed
Factors influencing the writing of AD after an ICU stay1 yearFactors such as lenght of stay in ICU, lenght of hospitalisation, duration of mechanical ventilation /sedation and the existence of PTSD (PCLS) or anxiety/ depression (HADS) will be evaluated and their influence on the completion of AD
Evaluation of the privileged interlocutor to discuss AD1 yearThe privileged interlocutor to discuss AD will be observed
Evaluation of the privileged interlocutor to complete AD1 yearThe privileged interlocutor to complete AD will be observed

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026